Search results
This Stock Just More Than Doubled in 1 Day: Is It a Buy?
Motley Fool via Yahoo Finance· 6 days agoThe biotech has come a long way since its not-so-successful attempt at dominating the coronavirus ...
This Stock Just More Than Doubled in 1 Day: Is It a Buy? | The Motley Fool
The Motley Fool· 6 days agoThe biotech has come a long way since its not-so-successful attempt at dominating the coronavirus ...
Better Buy: Inovio Pharmaceuticals vs. Novavax
Motley Fool via Yahoo Finance· 3 days agoThere are much more attractive stocks in the biotech industry. Should you invest $1,000 in Novavax right now? Before you buy stock in Novavax< ...
Shah Capital ends campaign against Novavax board after Sanofi deal
Reuters via AOL· 5 days agoUnder a deal signed on May 10, the French drugmaker will take a 4.9% stake in Novavax for $70...
Novavax, Inc. (NASDAQ:NVAX) Given Average Recommendation of “Hold” by Brokerages
ETF DAILY NEWS· 5 days agoNovavax, Inc. (NASDAQ:NVAX – Get Free Report) has been given an average recommendation of “Hold” by the five analysts that are presently covering the firm, Marketbeat.com ...
Shah Capital ends campaign against Novavax board after Sanofi deal
KFGO· 5 days ago(Reuters) - Hedge fund Shah Capital said on Monday it would withdraw its campaign against the...
Novavax investor drops proxy battle in wake of big pharma deal - Washington Business Journal
The Business Journals· 5 days agoA Novavax Inc. shareholder that had been waging a campaign to oust three board members has withdrawn...
Novavax Unusual Options Activity For May 23 - Novavax (NASDAQ:NVAX)
Benzinga· 2 days agoThe company generates maximum revenue from Europe. After a thorough review of the options trading surrounding Novavax, we move to examine the company in more detail. This ...
Shah Capital ends campaign against Novavax board after Sanofi deal
Reuters· 5 days agoUnder a deal signed on May 10, the French drugmaker will take a 4.9% stake in Novavax for $70...
Better Buy: Inovio Pharmaceuticals vs. Novavax | The Motley Fool
The Motley Fool· 3 days agoThe COVID-19 vaccine was worth tens of billions of dollars, but most of it went into the hands of...